BELGIAN BIOSAFETY CLEARING-HOUSE
UNEP International Technical Guidelines for Safety in Biotechnology

[Contents] [Previous] [Next]

Annex 5

EXAMPLES OF RISK-MANAGEMENT MEASURES FOR CONTROLLED RELEASES

Risk management is employed during the development and evaluation of an organism in a systematic fashion, for example from the laboratory, through stages of field testing, to commercialization. The number and forms of these stages are not fixed, but depend on the outcome of risk assessment at the different stages. Progression through the appropriate developmental stages, in order to gain knowledge, generally entails a reduction in control and possibly in monitoring, while often increasing in scale.

Appropriate risk management measures for releases will vary considerably from case to case. They will be determined by the risk assessment, the organisms involved and the way that they will be released. In addition to general precautions to control releases, risk management measures often focus on the control of the dissemination of the released organisms and control of the gene flow from the released organisms.

The type of risk-management measures to be employed should be commensurate with the risks identified. Therefore, there might be cases where very few, if any, risk management measures will be necessary. Consequently, not all of the examples given below are likely to be relevant for any given controlled release.

Examples of risk-management measures for controlled releases include:

General precautions

For plants

For animals

For micro-organisms

These measures will often not be applicable once an organism with novel traits, such as a modified crop plant, is at the stage of being marketed as a product if, as a result of testing during research and development, it has been shown that the risks are acceptably low.


BELGIAN BIOSAFETY CLEARING-HOUSE
UNEP International Technical Guidelines for Safety in Biotechnology

[Contents] [Previous] [Next]